Effects of probiotic (Primalac 454) on nonalcoholic fatty liver disease in broilers;Effets d'un probiotique sur la surcharge lipidique intrahépatique de nature non alcoolique chez le poulet

Revue de Medecine Veterinaire

Volumn 162, Issue 7, 2011, Pages 371-376

  Yalcin S S ^a   Gucer S ^a   Yalcin S ^b   Onbasilar I ^a   Kale, G ^a   Coskun T ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Blood biochemistry; Carcass trait; Nonalcoholic steatohepatitis

Indexed keywords

AVES; GALLUS GALLUS;

EID: 80053274439     PISSN: 00351555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. nd edition, Her Majesty's Stationery Office, London, 1981, pp.: 156-157.
2. th edition, AOAC International, Maryland, 2000, Chapter 4, pp.: 1-41.
3. AWAD W.A., GHAREEB K., ABDEL-RAHEEM S., BÖHM J.: Effects of dietary inclusion of probiotic and synbiotic on growth performance, organ weights, and intestinal histomorphology of broiler chickens. Poult. Sci., 2009, 88, 49-56.
4. BAJAJ J.S., SAEIAN K., CHRISTENSEN K.M., HAFEEZULLAH M., VARMA R.R., FRANCO J., PLEUSS J.A., KRAKOWER G., HOFFMANN R.G., BINION D.G.: Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am. J. Gastroenterol., 2008, 103, 1707-1715.
5. BLEI A.: Hepatic encephalopathy. In: Oxford textbook of clinical hepatology, BIRCHER J., BENHAMOU J.P., Mc INTYRE N. and RIZZETTO M. (eds), Oxford Medical Publications, Oxford, 1999, pp.: 765-783.
6. CHEN K.L., KHO W.L., YOU S.H., YEH R.H., TANG S.W., HSIEH CW.: Effects of Bacillus subtilis var. natto and Saccharomyces cerevisiae mixed fermented feed on the enhanced growth performance of broilers. Poult. Sci., 2009, 88, 309-315.
7. DAVIS G.S., ANDERSON K.E.: The effects of feeding the direct-fed microbial, primalac, on growth parameters and egg production in single comb white leghorn hens. Poult. Sci., 2002, 81, 755-759.
8. ERHUMA A., SALTER A.M., SCULLEY D.V., LANGLEY-EVANS S.C., BENNETT A.J.: Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat. Am. J. Physiol. Endocrinol. Metab, 2007, 292, E1702-1714.
9. FARESE G., SCHMIDT J.L., MAGER M.: An automated method for the determination of serum calcium with glyoxal bis (2-hydroxyanil). Clin. Chem., 1967, 13, 515-520.
10. KHAN M., RAOULT D., RICHET H., LEPIDI H., LA SCOLA B.: Growth-promoting effects of single-dose intragastrically administered probiotics in chickens. Br. Poult. Sci., 2007, 48, 732-735.
11. LEE K.W., LEE S.H., LILLEHOJ H.S., LI G.X., JANG S.I., BABU U.S., PARK M.S., KIM D.K., LILLEHOJ E.P., NEUMANN A.P., REHBERGER T.G., SIRAGUSA G.R.: Effects of direct-fed microbials on growth performance, gut morphometry, and immune characteristics in broiler chickens. Poult. Sci., 2010, 89, 203-216.
12. yNutrition, 3rd edition, University Books, Guelph, Canada, 2005, pp.: 80.
13. LI Z., YANG S., LIN H., HUANG J., WATKINS P.A., MOSER A.B., DESIMONE C., SONG X.Y., DIEHL A.M.: Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology, 2003, 37, 343-350.
14. LI S.P., ZHAO X.J., WANG J.Y:. Synergy of Astragalus polysaccharides and probiotics (Lactobacillus and Bacillus cereus) on immunity and intestinal microbiota in chicks. Poult. Sci., 2009, 88, 519-525.
15. LIRUSSI F., AZZALINI L., ORANDO S., ORLANDO R., ANGELICO F:. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst. Rev., 2007, 1, CD004996.
16. LIU Q., DUAN Z.P., HA D.K., BENGMARK S., KURTOVIC J., RIORDAN S.M.: Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology, 2004, 39, 1441-1449.
17. LOGUERCIO C., DE SIMONE T. FEDERICO A., TERRACCIANO F., TUCCILLO C., DI CHICCO M., CARTENI M.: Gut-liver axis: a new point of attack to treat chronic liver damage? Am. J. Gastroenterol., 2002, 97, 2144-2146.
18. LOGUERCIO C., FEDERICO A., TUCCILLO C., TERRACCIANO F., D'AURIA M.V., DE SIMONE C., DEL VECCHIO BLANCO C.: Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J. Clin. Gastroenterol., 2005, 39, 540-543.
19. MALAGUARNERA M., GRECO F., BARONE G., GARGANTE M.P., MALAGUARNERA M., TOSCANO M.A.: Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig. Dis. Sci., 2007, 52, 3259-3265.
20. MATTEONI C.A., YOUNOSSI Z.M., GRAMLICH T., BOPARAI N., LIU Y.C., Mc CULLOUGH A.J.: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 1999, 116, 1413-1419.
21. NANJI A.A., KHETTRY U., SADRZADEH S.M.: Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Pmc. Soc. Exp. Biol. Med., 1994, 205, 243-247.
22. NEUSCHWANDER-TETRI B.A., CALDWELL S.H.: Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology, 2003, 37, 1202-1219.
23. NGOC LAN P.T., BINH T., BENNO Y.: Impact of two probiotic Lactobacillus strains feeding on fecal lactobacilli and weight gains in chicken. J. Gen. Appl Microbiol., 2003, 49, 29-36.
24. O'DEA E.E., FASENKO G.M., ALLISON G.E., KORVER D.R., TANNOCK G.W., GUAN L.L.: Investigating the effects of commercial probiotics on broiler chick quality and production efficiency. Poult. Sci., 2006, 85, 1855-1863.
25. PEREG D., KOTLIROFF A., GADOTH N., HADARY R., LISHNER M., KITAY-COHEN Y.: Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study. Nutrition, 2011, 27, 177-181.
26. RAHIMI S., GRIMES J.L., FLETCHER O., OVIEDO E., SHELDON B.W.: Effect of a direct-fed microbial (Primalac) on structure and ultrastructure of small intestine in turkey poults. Poult. Sci., 2009, 88, 491-503.
27. ROLFE R.D.: The role of probiotics cultures in the control of gastrointestinal health. J. Nutr., 2000, 130, 396S-402S.
28. SOLGA S.F., DIEHL A.M.: Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J. Hepatol., 2003, 38, 681-687.
29. TALEBI A., AMIRZADEH B., MOKHTARI B., GAHRI H.: Effects of a multi-strain probiotic (PrimaLac) on performance and antibody responses to Newcastle disease virus and infectious bursal disease virus vaccination in broiler chickens. Av. Pathol., 2008, 37, 509-512.
30. VELAYUDHAM A., DOLGANIUC A., ELLIS M., PETRASEK J., KODYS K., MANDREKAR P., SZABO G.: VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a dietinduced nonalcoholic steatohepatitis model in mice. Hepatology, 2009, 49, 989-997.
31. WIGG A.J., ROBERTS-THOMSON I.C., DYMOCK R.B., Mc CARTHY P.J., GROSE R.H., CUMMINS A.G.: The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of nonalcoholic steatohepatitis. Gut, 2001, 48, 206-211.